Adrenergic Antagonist Drugs

(From Dr. Nardell’s ANS Physiology Handout, by  Brian Buschman)

 

Return to Semester Two Goodies

Return to The Unofficial Ross Page

 

Nonselective a-agonists (phenotybenzane and phentolamine)

Actions

 

Phenotybenzane is an irreversible a-blocker which when given at high doses causes blockage of muscarinic, seretonergic and histaminergic receptors.  It also blocks catacholamine reuptake.

 

a1-Antagonists (prazosin)

Prazosin has the same effects as phenotybenzane or phentolamine except for a lack of increased insulin secretion since prazosin only blocks a1 receptors and not a2.

 

a2 Antagonists (yohimbine)

Causes increase in insulin secretion due to blockage of a2 receptors.

 

Adverse Effects of a-agonists

 

Therapeutic Uses of a-agonists

 

b-antagonists (propranolol)

 

ab-receptor antagonists (labetalol and carvedilol)

Labetalol has partial agonist effects on b-receptors.

Carvedilol has no partial agonist effects.

 

 

Adverse Effects of b-receptor Antagonists

 

Therapeutic Uses of b-blockers

 

Contraindications

 

Indirect Acting antiadrenergic Drugs

Guanethidine is a false NT that blocks the release of NE.

 

Metyrosine which as we have seen blocks the conversion of tyrosine to L-DOPA.

 

Reserpine which as we already know blocks the uptake of NE into vesicles in the neuron.

 

 

Return to Semester Two Goodies

Return to The Unofficial Ross Page

 

Google